Stephen L Silvestro insider trades

Open-market stock purchases and sales by Stephen L Silvestro, Chief Executive Officer at OptimizeRx Corp, from SEC Form 4 filings since May 2, 2019.

Track record: 0% of 1 scored buy are up 5% or more since purchase, averaging -67%.

Recent trades

DateStockTradeValue
May 15, 2026OPRX OptimizeRx CorpSold (not open market)$27.2K
Dec 23, 2025OPRX OptimizeRx CorpSold (not open market)$42.8K
Dec 23, 2025OPRX OptimizeRx CorpSold (not open market)$42.8K
Dec 19, 2025OPRX OptimizeRx CorpBought (not open market)—
Dec 19, 2025OPRX OptimizeRx CorpSold (not open market)$21.5K
Oct 3, 2025OPRX OptimizeRx CorpSold$30.4K
Oct 3, 2025OPRX OptimizeRx CorpBought (not open market)—

Companies traded

  • OPRX OptimizeRx Corp: 1 buy, 9 sales, last May 15, 2026

Get free alerts when Stephen L Silvestro files a new trade →